Fluoride Hafnium/Zirconium-Softened Nanoprobes for Near-Infrared-IIb and CT Dual-Mode Bioimaging.
Hang ShangguanQiang WangShuang LiuChunsheng LiJiawei QuYujie CuiZhengyang TangYaru HuangNa NiuJiating XuPublished in: Nano letters (2024)
Fluoride-based lanthanide-doped nanoparticles (LDNPs) featuring second near-infrared (NIR-II, 1000-1700 nm) downconversion emission for bioimaging have attracted extensive attention. However, conventional LDNPs cannot be degraded and eliminated from organisms because of an inert lattice, which obstructs bioimaging applications. Herein, the core-shell LDNPs of Na 3 HfF 7 :Yb,Er@CaF 2 :Ce,Zr(Hf) [labeled as Zr(Hf)Ce-HC] with pH-selective and tunable degradability were synthesized for dual-modal bioimaging. Notably, the "softening" lattice of the Na 3 HfF 7 matrix and different Zr 4+ (Hf 4+ ) doping amounts in the shell enable Zr(Hf)Ce-HC with acidity-dependent and tunable degradability. After coating of an optimized Ce 3+ -doped CaF 2 :Zr shell, the near-infrared-IIb (NIR-IIb, 1500-1700 nm) luminescence intensity of ZrCe-HC is enhanced by 5.2 times compared with that of Na 3 HfF 7 :Yb,Er. The Hf element with high X-ray attenuation allows ZrCe-HC as the contrast agent for computed tomography (CT) bioimaging. The modification of oxidized sodium alginate endows ZrCe-HC with satisfying biocompatibility for NIR-IIb/CT dual-modal bioimaging. These findings would benefit the bioimaging applications of degradable fluoride-based LDNPs.
Keyphrases
- quantum dots
- energy transfer
- fluorescent probe
- computed tomography
- pet imaging
- dual energy
- living cells
- photodynamic therapy
- contrast enhanced
- positron emission tomography
- image quality
- acute heart failure
- fluorescence imaging
- drinking water
- magnetic resonance imaging
- magnetic resonance
- high resolution
- drug release
- working memory
- drug delivery
- highly efficient